the recent concerns about calcium blockers decreasing survival

Maybe there really is something to all the recent concerns about calcium blockers decreasing survival...especially short-acting nifedipine and other calcium blockers in the dihydropyridine class.

At first many experts dismissed this as too preliminary.

Now a third study shows similar results...this time a decrease in survival in elderly patients taking short-acting nifedipine for hypertension.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote